Furthermore, we showed that there is a significant interaction between IL17A and IL17F polymorphisms, treatments (surgery, chemotherapy and radiotherapy) and TNM stage of the disease in CRC patients (Table 5). The gene discussed is IL17A; the disease is colorectal carcinoma.